ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 121713 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 121713; 2) Community: the network communities that were significantly associated with the response to NSC 121713; 3) Molecule: the relationships between components within communities and NSC 121713; 4) MDR: the compounds that were significantly associated with the NSC 121713.

NSC Compound Enrichment Correlation
NSC 752464 methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate 0.0220039422291538 0.42839641
NSC 79304 Null 0.0220039422291538 0.4545281
NSC 109836 Null 0.0220039422291539 0.25228025
NSC 112758 Rubomycin 0.0220039422291539 0.13865916
NSC 748904 [(20S)-20-(N,N-dimethylamino)-5a-preg-3a-aminal], N-formylchonemorphine 0.0220039422291541 0.21860199
NSC 142475 Null 0.0228801759885687 0.42378218
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0228801759885687 0.073273854
NSC 180973 Tamoxifen citrate 0.0228801759885687 0.28963833
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0228801759885687 0.35071614
NSC 245456 Naphthalene, 2,3-dimethoxy-6-(2-nitroethenyl)- 0.0228801759885687 0.26651257
Total:99  Current:50    [First] [Prev] [Next] [Last]